141 related articles for article (PubMed ID: 12022882)
21. Role of the alpha-helix 163-170 in factor Xa catalytic activity.
Levigne S; Thiec F; Cherel G; Irving JA; Fribourg C; Christophe OD
J Biol Chem; 2007 Oct; 282(43):31569-79. PubMed ID: 17726015
[TBL] [Abstract][Full Text] [Related]
22. Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.
Ahnström J; Gierula M; Temenu J; Laffan MA; Lane DA
J Thromb Haemost; 2020 Jan; 18(1):136-150. PubMed ID: 31466141
[TBL] [Abstract][Full Text] [Related]
23. Determinants of specificity of factor xa interaction with its physiological inhibitors.
Rezaie AR
Mini Rev Med Chem; 2006 Aug; 6(8):859-65. PubMed ID: 16918492
[TBL] [Abstract][Full Text] [Related]
24. The role of autolysis loop in determining the specificity of coagulation proteases.
Yang L; Manithody C; Rezaie AR
Braz J Med Biol Res; 2007 Aug; 40(8):1055-64. PubMed ID: 17665041
[TBL] [Abstract][Full Text] [Related]
25. The functional role of the autolysis loop in the regulation of factor X upon hemostatic response.
Bonde AC; Lund J; Hansen JJ; Winther JR; Nielsen PF; Zahn S; Tiainen P; Olsen OH; Petersen HH; Bjelke JR
J Thromb Haemost; 2022 Mar; 20(3):589-599. PubMed ID: 34927362
[TBL] [Abstract][Full Text] [Related]
26. Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va binding.
Rudolph AE; Porche-Sorbet R; Miletich JP
Biochemistry; 2000 Mar; 39(11):2861-7. PubMed ID: 10715105
[TBL] [Abstract][Full Text] [Related]
27. Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex.
Yang L; Manithody C; Qureshi SH; Rezaie AR
Biochemistry; 2008 Jun; 47(22):5976-85. PubMed ID: 18457426
[TBL] [Abstract][Full Text] [Related]
28. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Olson ST; Rezaie AR
J Biol Chem; 2003 Jul; 278(27):25032-8. PubMed ID: 12721300
[TBL] [Abstract][Full Text] [Related]
29. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
30. Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex.
Chen L; Yang L; Rezaie AR
J Biol Chem; 2003 Jul; 278(30):27564-9. PubMed ID: 12750382
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide.
Quinsey NS; Whisstock JC; Le Bonniec B; Louvain V; Bottomley SP; Pike RN
J Biol Chem; 2002 May; 277(18):15971-8. PubMed ID: 11854268
[TBL] [Abstract][Full Text] [Related]
32. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.
Franssen J; Salemink I; Willems GM; Wun TC; Hemker HC; Lindhout T
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):33-7. PubMed ID: 9173898
[TBL] [Abstract][Full Text] [Related]
33. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.
Yang L; Manithody C; Rezaie AR
Blood; 2004 Sep; 104(6):1753-9. PubMed ID: 15178583
[TBL] [Abstract][Full Text] [Related]
34. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Qureshi SH; Rezaie AR
J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
Stevic I; Berry LR; Chan AK
J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
Rezaie AR
Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
[TBL] [Abstract][Full Text] [Related]
37. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
38. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
39. Fibroblasts, glial, and neuronal cells are involved in extravascular prothrombin activation.
Yamazaki Y; Shikamoto Y; Fukudome K; Kimoto M; Morita T
J Biochem; 1999 Oct; 126(4):655-61. PubMed ID: 10502671
[TBL] [Abstract][Full Text] [Related]
40. Contribution of residue 192 in factor Xa to enzyme specificity and function.
Rezaie AR; Esmon CT
J Biol Chem; 1995 Jul; 270(27):16176-81. PubMed ID: 7608183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
